/EINPresswire.com/ -- DUBLIN, IRELAND--(Marketwired - March 23, 2016) - Research and Markets has announced the addition of the "Neuromodulation Devices Global Market - Forecast To 2021" report to their offering.

The global neuromodulation devices market is expected to grow at a double digit CAGR to reach $9.3 billion by 2021.

Factors driving the neuromodulation market include, projected increase in patients with chronic pain, neurodegenerative diseases, psychiatric conditions, improvements in technology such as miniaturization, better battery technology, use of bio active coatings are all contributing for growth of neuromodulation devices.

However, the risk of side effects, availability of alternative treatment and high initial cost of implants are the factors hampering the market growth. Advancement of technology with its wide application areas shows that neuromodulation devices market has vast opportunities in the coming years.

Neuromodulation devices market is segmented on the basis of technology as internal and external neuromodulation. The internal neuromodulation is again classified into the following:

• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Other with Gastric Electric Stimulation (GES)
• Respiratory Electrical Stimulation (RES)/Phrenic Nerve Stimulation (PNS).

North America accounts for the highest market share of 56.1% followed by Europe. Steep rise in ageing population, advancement in technology, awareness of people and favourable government policies makes U.S. the leader of neuromodulation devices market. However, Asian countries especially India and China are the fast growing regions with its growing demand for neuromodulation devices.

Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Market, By Technology

5 Market, By Applications

6 Market, By End-Users

7 Regional Analysis

8 Company Developments

9 Company Profiles

Companies Profiled:

• Avery Biomedical
• Boston Scientific
• Cogentix Medical (Uroplasty, Inc)
• Cyberonics (Livanova)
• Magstim
• Medtronic
• Neurometrix Inc
• Neuronetics Inc
• Nevro Corporation
• St. Jude Medical
• Synapse Biomedical

For more information visit http://www.researchandmarkets.com/research/szxvv9/neuromodulation

Sector: Neurology Devices

Image Available: http://www.marketwire.com/library/MwGo/2016/3/23/11G088849/Images/neuromodulation_devices_global_market_forecast-131f80b7d771a49cb3289702c879929d.jpg

Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.